Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

BACKGROUND: Despite targeted antiemetics, data support an unmet need related to the management of delayed nausea and vomiting (NV). Promising pilot data informed this phase III trial evaluating gabapentin for delayed NV from highly emetogenic chemotherapy (HEC). METHODS: Participants were randomized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Barton, Debra L., Thanarajasingam, Gita, Sloan, Jeff A., Diekmann, Brent, Fuloria, Jyotsna, Kottschade, Lisa A., Lyss, Alan P., Jaslowski, Anthony J., Mazurczak, Miroslaw A., Blair, Scott C., Terstriep, Shelby, Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221473/
https://ncbi.nlm.nih.gov/pubmed/25043153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados